Great Information, Real Community, Better Living.
 Main Page
 Shoulder News
Feature Story
Shoulder Technology
Real Life Recoveries
 Education Center
 Shoulder  Hero™
Dr. Evan Flatow:
Innovating Shoulder Surgery
About Heroes
 Join the Discussion in  Our Forums
Shoulder1 Forums
Patient Stories
Shoulder Journals
Ask an Expert
Locate a Doctor
Reference Library
Video Library
 Bookmark Us
Search the Body1 Network
April 19, 2021  
SHOULDER NEWS: Feature Story

  • Print this Article
  • Email this Article
  • Links/Reprints
  • Remicade Helps Kids Cope with Arthritis

    Remicade Helps Kids Cope with Arthritis

    April 21, 2005

    By: Laurie Edwards for Shoulder1

    For children who suffer from arthritis, the running, jumping and playing common for their peers is often hampered by pain, stiffness and fatigue. However, Italian researchers have some encouraging news for these kids: repeated infusions of Remicade, a newer anti-arthritis medication, decreased the number of joints with active disease and lessened pain and inflammation.

    Learn More
    For more information on juvenile idiopathic arthritis, visit:

    GE Healthcare

    For more information on Remicade and similar drugs,

    click here

    Get the latest on methotrexate


    Calling their results – reported in Arthritis and Rheumatism – “clinically impressive,” the Italian team followed 24 patients with juvenile idiopathic arthritis (JIA).

    JIA is extremely rare and is a general term for a host of symptoms and subgroups in children under 16. It is characterized by six weeks or more of joint swelling as well as a combination of joint tenderness, limited range of motion and heat surrounding the joint. From there, the disease is further classified depending if it affects less than five or less than four joints at one time or if it more systemic, the most rare form.

    In severe resistant cases such as the ones in the Italian study, JIA can lead to long-term joint and cartilage damage.

    Unlike many arthritis drugs making news lately, namely Vioxx and Celebrex, Remicade (known generically as infliximab) is what is called a biologic response modifier, meaning it is derived from living sources and helps stimulate the immune system to fight against inflammation and infection.

    In a course of treatment similar to most people prescribed Remicade, the children in the study were given a starting infusion of the drug, two more doses after two and six weeks and an infusion every eight weeks thereafter.

    All participants were also given weekly injections of methotrexate, a powerful drug targeting rapidly-growing cells that is often used to treat cancers.

    After the first infusion, the children reported less stiffness and pain and increased energy levels. While the average number of joints affected started out at six, it dropped to two after 14 days, and after six months and one year, the number of joints affected had dropped all the way to zero.

    ”Despite the fact that this was a very severely affected group of patients, [one-third] did not have joints with active disease at the last visit,” the team said.

    While 12 children did experience negative events during the actual infusions, they were not serious. While further studies are needed in this area, so far Remicade looks like an effective and safe alternative for children with resistant forms of JIA.

    Last updated: 21-Apr-05


  • Add Comment
    Interact on Shoulder1

    Discuss this topic with others.
    Feature Archives

    Surgery A Treatment Option For Young Patients With Shoulder Injuries

    Recommendations For Tablet Computer Use To Avoid Shoulder Pain

    3-D Motion Detection System Could Prevent Shoulder Injuries In Baseball Pitchers

    New IDSA Guidelines Aim To Reduce Death, Disability And Cost Of Prosthetic Joint Infections

    Biceps Tenodesis Hastens Recovery From Shoulder Injuries

    Previous 5 Features ...

    Next 5 Features ...

    More Features ...
    Related Multimedia

    Interview with Dr. Patel: Roles for arthroscopic surgery in osteoarthritis/hip resurfacing

    Interview with Dr. Patel: The Reasons for Back Pain and Diagnostic Methods

    Interview with Dr. Prodromos: High Tibial Osteotomy 1

    More Features ...
    Related Content
    Remicade Offers Relief for Arthritic Children

    Endurance Of Total Knee Replacements In Younger Patients With Juvenile Arthritis

    Healthy Diet = Healthy Joints

    The Achy Generation: Baby-Boomers, Obesity and Arthritis

    About turn for Bextra – FDA calls for withdrawal of drug and increased warnings on NSAIDs

    More Features ...
    Home About Us Press Jobs Advertise With Us Contact Us
    © 2021 Body1 All rights reserved.
    Disclaimer: The information provided within this website is for educational purposes only and is not a substitute for consultation with your physician or healthcare provider. The opinions expressed herein are not necessarily those of the Owners and Sponsors of this site. By using this site you agree to indemnify, and hold the Owners and Sponsors harmless, from any disputes arising from content posted here-in.